FDA Inspection 1095823 — Mark E. Pennesi, MD, PhD
The FDA completed an inspection of Mark E. Pennesi, MD, PhD on July 3, 2019 in Portland, OR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 3, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Portland, OR (United States)
Additional Details
Clinical Investigator (CI)